Hong, Sang-Won
KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer. [electronic resource]
- Cancer letters May 2013
- 74-82 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1872-7980
Standard No.: 10.1016/j.canlet.2013.01.015 doi
Subjects--Topical Terms: Aminopyridines--chemistry Angiogenesis Inhibitors--chemistry Animals Antigens, CD34--metabolism Apoptosis--drug effects Benzoxazoles--chemistry Caspase 3--metabolism Cell Line, Tumor Cell Proliferation--drug effects DNA Fragmentation Dose-Response Relationship, Drug Extracellular Signal-Regulated MAP Kinases--metabolism Flow Cytometry G2 Phase Cell Cycle Checkpoints--drug effects Human Umbilical Vein Endothelial Cells--drug effects Humans MAP Kinase Kinase Kinases--metabolism Male Mice Mice, Inbred BALB C Mice, Nude Models, Molecular Molecular Structure Neovascularization, Physiologic--drug effects Phosphatidylinositol 3-Kinase--metabolism Phosphorylation Poly(ADP-ribose) Polymerases--metabolism Protein Kinase Inhibitors--chemistry Proto-Oncogene Proteins c-akt--metabolism Proto-Oncogene Proteins c-met--antagonists & inhibitors Rats Rats, Sprague-Dawley Signal Transduction--drug effects Stomach Neoplasms--blood supply Time Factors Tissue Culture Techniques Tumor Burden--drug effects Xenograft Model Antitumor Assays